Zhejiang Xianju Pharmaceutical Co Ltd. Stock Analysis 002332.SZ

Zhejiang Xianju Pharmaceutical Co., Ltd. engages in the manufacture and sale of steroid and hormone drugs. The company is headquartered in Taizhou, Zhejiang and currently employs 3,209 full-time employees. The company went IPO on 2010-01-12. The firm's main products include corticosteroid drugs, sex hormone drugs (gynecological and family planning drugs), anesthetic muscle relaxants and respiratory drugs. The firm's products are mainly used to treat rheumatoid arthritis, bronchial asthma, eczema and other skin diseases, anaphylactic shock, prostatitis and other endocrine diseases, and can also be used for contraception, pregnancy, relief of female menopausal symptoms, surgical anesthesia and other aspects. The firm mainly operates its businesses in the domestic and overseas markets.